Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 50015865
TargetIntegrin alpha-V/beta-5(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161784(3-{5-[3-(Pyridin-2-ylamino)-propoxy]-indol-1-yl}-p...)
Affinity DataIC50: 2.5nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161783(3-{5-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-indol...)
Affinity DataIC50: 49nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161781(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 140nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161783(3-{5-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-indol...)
Affinity DataIC50: 210nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161781(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 300nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161782(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 330nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161782(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 420nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-V/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161784(3-{5-[3-(Pyridin-2-ylamino)-propoxy]-indol-1-yl}-p...)
Affinity DataIC50: 470nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161781(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 7.80E+3nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161783(3-{5-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-indol...)
Affinity DataIC50: 1.50E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161781(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161782(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161784(3-{5-[3-(Pyridin-2-ylamino)-propoxy]-indol-1-yl}-p...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-IIb/beta-3(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161783(3-{5-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-indol...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161782(3-{6-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-benzo...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetIntegrin alpha-5/beta-1(Human)
Johnson and Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50161784(3-{5-[3-(Pyridin-2-ylamino)-propoxy]-indol-1-yl}-p...)
Affinity DataIC50: 2.00E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed